International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Oseltamivir Phosphate 15 mg/mL in SyrSpend SF

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s): 323

Oseltamivir Phosphate 15 mg/mL in SyrSpend SF Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Oseltamivir Phosphate 15 mg/mL in SyrSpend SF. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V Allen, Jr., PhD, RPh, formulation, oseltamivir phosphate, antiviral agent, neuraminidase inhibitor, influenza, flu prevention

Related Categories: FORMULATIONS, INFECTIOUS DISEASE, PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Oseltamivir Phosphate 15 mg/mL in SyrSpend SF Allen Loyd V Jr	Jul/Aug 2018 Pg. 323
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Voudrie Mark A II, Allen D Brett	Jan/Feb 2010 Pg. 82-85
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2019 Pg. 231
Oseltamivir 12-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2007 Pg. 332
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 315
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Ford Stephen M, Kloesel Lawson G, Grabenstein John D	Mar/Apr 2007 Pg. 164-176
Chloroquine Phosphate 15-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 138
Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid	May/Jun 2017 Pg. 240-241
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Phenytoin 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 147
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul	Sep/Oct 2015 Pg. 420-427
Ranitidine 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2018 Pg. 56
Fludarabine Phosphate 25-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 143
Codeine Phosphate 3 mg/mL in Ora-Sweet Allen Loyd V Jr	Mar/Apr 2022 Pg. 141
Return to Top